<cite id="3llb5"><video id="3llb5"><menuitem id="3llb5"></menuitem></video></cite><menuitem id="3llb5"><video id="3llb5"></video></menuitem>
<cite id="3llb5"><video id="3llb5"></video></cite>
<cite id="3llb5"><video id="3llb5"><menuitem id="3llb5"></menuitem></video></cite>
<cite id="3llb5"></cite>
<cite id="3llb5"><video id="3llb5"><menuitem id="3llb5"></menuitem></video></cite><cite id="3llb5"><strike id="3llb5"><thead id="3llb5"></thead></strike></cite>
<var id="3llb5"></var>
<cite id="3llb5"></cite>
<var id="3llb5"></var>
<menuitem id="3llb5"><video id="3llb5"></video></menuitem>
<var id="3llb5"></var><cite id="3llb5"><video id="3llb5"><menuitem id="3llb5"></menuitem></video></cite>

orSign up

Português Follow us:
wechat
能免费看Av的网站_可以直接看片的网站_一级a做爰片_日本毛片免费视频观看_手机免费在线电影

China adds 119 drugs to medicare reimbursement list

2020-December-29       Source: Xinhuanet.com

The inclusions also helped expand the scope of reimbursement to cover more diseases including COVID-19.

Experts discuss at a meeting on the adjustment of the national medical insurance reimbursement list in Beijing, capital of China, Oct. 18, 2020. China has included 119 more kinds of drugs in its national medical insurance reimbursement list, delivering greater price cuts and benefiting more people, the National Healthcare Security Administration (NHSA) said at a press conference Monday. Ninety-six of the new additions to the list are exclusive drugs that offer lower prices through negotiation and 16 were newly put on the market this year, the NHSA said. (Xinhua/Zhang Yuwei)

China has included 119 more kinds of drugs in its national medical insurance reimbursement list, delivering greater price cuts and benefiting more people, the National Healthcare Security Administration (NHSA) said at a press conference Monday.

Ninety-six of the new additions to the list are exclusive drugs that offer lower prices through negotiation and 16 were newly put on the market this year, the NHSA said.

Altogether, a record number of 162 drugs on the list were negotiated for price reduction. A deal was reached for 119 of the drugs, with their prices dropping an average of 50.64 percent.

The inclusions also helped expand the scope of reimbursement to cover more diseases including COVID-19. So far, all the medicines listed in China's latest diagnosis and treatment scheme for COVID-19 have been added to the reimbursement list, the NHSA said.

China currently has 2,800 kinds of medicines on the medicare reimbursement list, including 1,374 traditional Chinese patent medicines.

Editor: 张诗雨

Scan to share on WeChat

Scan to follow us on WeChat

0
Related News
Most popular
Day |
Week |
Month
Key Words

Home|About us|Contact us|Southcn.com

www.fhtd8.com. All rights reserved.

www.fhtd8.com. All rights reserved.|Registered number 020074| 粤公网安备 44010402000511号|ICP备案号 粤B-20050235-8